Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia.
D000818:Animals; D046508:Culture Techniques; D003561:Cytarabine / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007739:L Cells; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008722:Methods; D051379:Mice; D013154:Spleen / Q000166:cytology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D003561:Cytarabine; D014316:Tritium; D004247:DNA; D013936:Thymidine